Kjell Göran Stenberg
Vorstandsvorsitzender bei Accequa AB
Profil
Kjell Göran Stenberg is the founder of Combio A, which was founded in 1975.
He is currently the Chief Executive Officer & Director at Accequa AB, Chief Executive Officer & Director at Celus Pharmaceuticals Ltd., Director at Novation Pharmaceuticals, Inc., and Owner at Biomedical Development Europe.
Dr. Stenberg's former positions include Chief Executive Officer at Cyxone AB, Chairman at Aptahem AB, Chief Operating Officer & Director at Medwell Capital Corp., Director at PCI Biotech Holding ASA, and Director at Galecto Biotech ApS.
He also held the position of Manager & Senior Researcher at Astra AB and AstraZeneca AB from 1975 to 2000.
Dr. Stenberg holds a doctorate from Karolinska Institutet and a graduate degree from Umea Universitet.
Aktive Positionen von Kjell Göran Stenberg
| Unternehmen | Position | Beginn |
|---|---|---|
| Accequa AB | Vorstandsvorsitzender | - |
Novation Pharmaceuticals, Inc.
 Novation Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Novation Pharmaceuticals, Inc. operates as a biotechnology research and development company. It provides modulation of intracellular messenger RNA (mRNA) to identify new small-molecule therapies to treat serious diseases. The company was founded by Dominique Cheneval and Tania Kastelic and is headquartered in Burnaby, Canada. | Direktor/Vorstandsmitglied | 01.11.2009 |
| Biomedical Development Europe | Corporate Officer/Principal | - |
| Celus Pharmaceuticals Ltd. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Kjell Göran Stenberg
| Unternehmen | Position | Ende |
|---|---|---|
Aptahem AB
 Aptahem AB Pharmaceuticals: MajorHealth Technology Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden. | Vorsitzender | 03.09.2020 |
| CYXONE AB | Vorstandsvorsitzender | 13.11.2019 |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Vorsitzender | 01.05.2013 |
| PCI BIOTECH HOLDING ASA | Direktor/Vorstandsmitglied | 01.05.2015 |
Medwell Capital Corp.
 Medwell Capital Corp. Investment ManagersFinance Medwell Capital Corp. operates as an investment and advisory firm which directly invests in and advises companies on strategy and corporate and technology development. It also provides clinical, regulatory and corporate advisory services. The company was founded on December 15, 1998 and is headquartered in Edmonton, Canada. | Geschäftsführer | - |
Ausbildung von Kjell Göran Stenberg
| Karolinska Institutet | Doctorate Degree |
| Umea Universitet | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| PCI BIOTECH HOLDING ASA | Health Technology |
 | Health Technology |
| CYXONE AB | Health Technology |
| Private Unternehmen | 9 |
|---|---|
Astra AB
 Astra AB Pharmaceuticals: MajorHealth Technology Astra AB used to manufacture and market cardiovascular preparations, local anesthetics, anti-infective agents and medical-care equipment. The firm's products were Pulmicort, Xylocaine, Marcaine, EMLA and Naropin. It had operations in Scandinavia, Europe, North & South America, Australia, New Zealand, Africa and Asia. The company was headquartered in Södertälje, Sweden. | Health Technology |
Medwell Capital Corp.
Medwell Capital Corp. Investment ManagersFinance Medwell Capital Corp. operates as an investment and advisory firm which directly invests in and advises companies on strategy and corporate and technology development. It also provides clinical, regulatory and corporate advisory services. The company was founded on December 15, 1998 and is headquartered in Edmonton, Canada. | Finance |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Novation Pharmaceuticals, Inc.
Novation Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Novation Pharmaceuticals, Inc. operates as a biotechnology research and development company. It provides modulation of intracellular messenger RNA (mRNA) to identify new small-molecule therapies to treat serious diseases. The company was founded by Dominique Cheneval and Tania Kastelic and is headquartered in Burnaby, Canada. | Health Services |
| Combio A/S | |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Health Technology |
| Accequa AB | |
| Biomedical Development Europe | |
| Celus Pharmaceuticals Ltd. |
